Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/ASO.2005.07.015
Annals of Surgical Oncology 12:800-807 (2005)
© 2005 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kubo, F.
Right arrow Articles by Aikou, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kubo, F.
Right arrow Articles by Aikou, T.

Original Article

Interleukin 8 in Human Hepatocellular Carcinoma Correlates With Cancer Cell Invasion of Vessels But Not With Tumor Angiogenesis

Fumitake Kubo, MD, Shinichi Ueno, MD, PhD, Kiyokazu Hiwatashi, MD, Masahiko Sakoda, MD, Koichi Kawaida, MD, Kensuke Nuruki, MD and Takashi Aikou, MD, PhD

Course of Advanced Therapeutics, Field of Oncology, Department of Surgical Oncology and Digestive Surgery, Kagoshima University Graduate School of Medicine and Dental Sciences, 8-35-1 Sakuragaoka Kagoshima, 890-8520, Japan

Correspondence: Address correspondence and reprint requests to: Fumitake Kubo, MD; E-mail: f-kubo{at}m3.kufm.kagoshima-u.ac.jp.

Background: Angiogenic factor seems necessary for the development of hepatocellular carcinoma (HCC), which is a hypervascular malignancy. This study examined the expression of interleukin (IL)-8, a potent angiogenic factor, in HCC samples.

Methods: We measured IL–8 expression by using reverse transcriptase-polymerase chain reaction in clinical HCC tissues from 45 patients who underwent surgical resection. We then assessed correlations between IL–8 expression and microvessel growth or clinicopathologic factors. We also elucidated the in vitro effect of IL–8 on HepG2 development by using fluorometric assays of proliferation, chemotaxis, and invasion.

Results: The expression of IL–8 did not significantly correlate with the microvessel count in HCC tissues, but the incidence of microscopic vessel invasion was significantly higher in IL–8–positive than in IL–8–negative tissues. Thus, more IL–8 was expressed in HCCs at pathologic stage III/IV than in those at stage I/II. Assays in vitro showed that IL–8 stimulates HepG2 chemotactic and invasive activities rather than cell proliferation.

Conclusions: The expression of IL–8 in human HCC has more relevance to metastatic potential, such as vessel invasion, than to angiogenesis or cell proliferation.

Key Words: Interleukin 8 • Hepatocellular carcinoma • Tumor progression • Angiogenesis • Chemotaxis • Vessel invasion




This article has been cited by other articles:


Home page
JEMHome page
C. Rolny, L. Capparuccia, A. Casazza, M. Mazzone, A. Vallario, A. Cignetti, E. Medico, P. Carmeliet, P. M. Comoglio, and L. Tamagnone
The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment
J. Exp. Med., May 12, 2008; 205(5): 1155 - 1171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society of Surgical Oncology.